Each year the "Strongers for Research" call awards individual mini-grants to under-40 young oncologists studying lung cancer. Here you find their stories, the research centre they work in, what they are working on now. Merit-based selection via independent Scientific Committee.
MD, Oncologist, PhD candidate in Translational Science
Azienda Ospedaliero-Universitaria di Parma
Immunotherapy DUAL-ITA study of how sex-related genetic and hormonal differences affect the efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced non-small cell lung cancer (NSCLC)....
4th-year resident in Medical Oncology
Azienda Ospedaliera Sant'Andrea, Roma
Supportive care Time ToxicityQuantifying the "time patients spend" on outpatient cancer care — visits, tests, treatments, waiting — as an under-recognised quality-of-life metric. Time toxicity is a dimension o...
Physician, Phase 1 Unit
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma
Biomarkers cfDNA-NSCLCIdentifying circulating biomarkers (cell-free DNA methylation + Integrated Stress Response transcripts) to predict response to immune checkpoint inhibitors in lung cancer. Goal: a...
The 2026 call will open in September. €3,000 mini-grants to under-40 oncologists working on lung cancer.
Discover the call Fund the next oneEvents, awarded grants, stories of the people who make research possible. One email a month, no spam.
